EBOS Group announces leadership change

AUCKLAND: EBOS Group Limited announced Wednesday that CEO John Cullity will retire on June 30, 2025. Adam Hall, currently Group Executive and President – Asia for Orica Limited, will succeed Cullity effective July 1, 2025.

Hall has an extensive background in strategic growth, mergers and acquisitions, and operational excellence. At Orica, he spearheaded significant earnings growth and innovation. He has also held senior roles at CF Industries and Bunge in the USA, UK, and Asia.

EBOS Chair Liz Coutts expressed confidence in Hall’s appointment: “Adam brings deep experience in driving operational efficiency and executing transformative M&A. His leadership will be instrumental as EBOS continues to pursue its growth ambitions.”

Cullity’s tenure saw EBOS deliver total shareholder returns of 168%, significantly outperforming the market. Coutts praised Cullity for shaping EBOS into a leader in healthcare and animal care across New Zealand, Australia, and Southeast Asia.

Hall remarked on his new role: “It’s a privilege to join this exceptional team. I look forward to working with the Board and the Executive Leadership Team to create further growth and innovation.”

Cullity reflected on his time at EBOS: “Since joining as CFO in 2009, I’ve had the privilege of working with exceptional people to grow the Group. Over the past decade, we have completed over 20 strategic acquisitions.”

Cullity extended his gratitude to Coutts, the Board, the Executive Leadership Team, and the Group’s 5,200 employees for their dedication to serving communities.